Siparex in the news

Desjardins increased its share in French partner Siparex Associés to accelerate European development and support clients.

Siparex Entrepreneurs acquired a majority stake in Koalys, a real estate diagnostics company, leading to a change in leadership and plans for network expansion.

Siparex Entrepreneurs 6 has acquired a majority stake in Koalys, a real estate diagnostics company, to fund its expansion and leadership transition.

Siparex Entrepreneurs 6 has acquired a majority stake in Koalys, a real estate diagnostics specialist, to fund its expansion and digital development.

Siparex Entrepreneurs acquired a majority stake in Koalys, a real estate diagnostics franchise expert.

Siparex Entrepreneurs acquired a majority stake in Koalys, the franchisor of Diagamter, leading to a leadership change and plans for expansion in key French cities.

Siparex has raised 400 million euros for its new fund, Siparex ETI 6, aimed at growing intermediate-sized enterprises.

Siparex closed its first funding round for Siparex ETI 6, securing 400 million euros to invest in French and European mid-sized companies, aiming to reach 625 to 750 million euros.

Siparex secures 400 million Euros for its ETI 6 fund, targeting lower mid-market growth companies in Europe with a focus on ESG.

Siparex's ETI 6 fund secured 400 million euros in its initial closing, targeting growth companies in lower mid-market across several European countries with a focus on healthcare and business services.

Siparex secured ‘400 million’ for its sixth mid-market fund, ETI 6, to invest in growing companies across Europe, focusing on buy-and-build strategies.

Kiping is raising capital from Siparex Entrepreneurs, necessitating careful negotiation of terms to manage growth financing, governance, and investor relations.

Siparex ETI 6 closed its first funding round at €400 million, targeting investments in healthcare, business services, and niche industrial mid-sized companies for growth and European expansion.

Siparex ETI 6 secures 400 million euros in its first closing to invest in European mid-cap growth companies across specific sectors.

Siparex ETI 6 secured its first closing at €400 million to invest in mid-sized companies in health, business services, and niche industries across Europe.

Siparex secured —400m for its sixth ETI buyout fund, targeting multi-user professional and enterprise packages.

Siparex's sixth fund for European ETIs achieved a 400 million euro first close, boosted by high reinvestment and quick capital returns from prior funds.

Siparex ETI 6 has raised 400 million euros to invest in high-growth companies in Spain, with individual investment tickets between 20 and 70 million euros.

Siparex raised 400M€ for its Siparex ETI 6 fund, which will invest in European mid-cap companies across healthcare, business services, and niche industries.

Siparex ETI 6, a new fund targeting lower mid-market growth companies in Europe, reached a 400 million euro first closing.